1. Research Objective and Assumption

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Solution Type
     • Market Snippet, By Technique Type
   • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Key Developments
   • Regulatory Scenario
   • PEST Analysis

4. Global Organ Preservation Solutions Market, By Solution Type, 2021 – 2033 (US$ Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022–2033
     • Segment Trends
   • Viaspan
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
     • Segment Trends
   • Custodiol HTK
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
     • Segment Trends
   • Renograf
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
     • Segment Trends
   • Hypothermosol
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
     • Segment Trends
   • Perfadex
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
     • Segment Trends
   • Lifor
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
     • Segment Trends
   • HBS Solution
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
     • Segment Trends
   • siRNA
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
     • Segment Trends
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
     • Segment Trends

5. Global Organ Preservation Solutions Market, By Technique Type, 2021 – 2033 (US$ Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022–2033
     • Segment Trends
   • Hypothermic Perfusion Preservation
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
   • Static Cold Storage
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)

6. Global Organ Preservation Solutions Market, By Regions, 2021 – 2033 (US$ Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022–2033
     • Segment Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
       • U.S.
       • Canada
   • Europe
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
       • U.K.
       • Germany
       • Italy
       • France
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
       • China
       • India
       • Japan
       • ASEAN
       • Australia
       • South Korea
       • Rest of Asia Pacific
   • Latin America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Middle East
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
       • North Africa
       • Central Africa
       • South Africa

7. Competitive Landscape

   • Company Profiles
     • Teva Pharmaceutical Industries Ltd.
       • Company Overview
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Franz Köhler Chemie GmbH
       • Company Overview
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • BioLife Solutions
       • Company Overview
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • XVIVO Perfusion AB
       • Company Overview
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Bristol-Myers Squibb, Inc.
       • Company Overview
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • ToleroTech, Inc.
       • Company Overview
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Lifeline Scientific
       • Company Overview
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Preservation Solutions Inc.
       • Company Overview
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Claris Injectables Limited
       • Company Overview
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • 21st Century Medicine
       • Company Overview
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Paragonix Technologies Inc.
       • Company Overview
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • BioTime, Inc.
       • Company Overview
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • CryoLife, Inc.
       • Company Overview
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies

8. Section

   • References
   • Research Methodology
   • About us and Sales Contact